SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jayhawk969 who wrote (4267)3/9/2000 2:50:00 PM
From: Don Miller   of 10280
 
I am not the one to take a risk opinion from, but here are my two cents.

1. The FTC issue had no basis, and is harming both companies due to the length of time and the frivolous nature of the issue. I question if SEPR/LLY do not have a harm case.

2. One major brokerage house said it would clear without impact by the end of next Qtr.

3. Worst case should there be a surprise, SEPR owns the patent and could go it alone or with another partner, however not using the Claritin trademark.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News